As of Nov 19, 2026, 1 of 2 active firms rate ORGO a Buy (1 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
ORGO EPS & revenue forecast
EPS · NEXT QUARTER
$-0.16
Range $-0.18 – $-0.14 · 2 analysts · -53% YoY
Next period, 2 analysts expect Organogenesis Holdings Inc to earn $-0.16 a share (range $-0.18 – $-0.14), versus $-0.34 a year earlier. Full-year consensus is $-1.43, growing to $-0.54 the year after.
REVENUE · NEXT QUARTER
$52.4M
Range $48.9M – $55.8M · 2 analysts · +41% YoY
Revenue is expected to reach $52.4M (range $48.9M – $55.8M), +40.6% year-over-year. Full-year consensus is $187.8M, rising to $234.7M next year.
Top analysts covering Organogenesis Holdings Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on ORGO.
#1
Ryan Zimmerman
BTIG · Rank #212
Buy
$8.00+848.4% to target
Overall win rate
37%
+ Follow
#2
Ross Osborn
Cantor Fitzgerald · Rank #238
Buy
$9.00+967.0% to target
Overall win rate
34%
+ Follow
#3
RM
Ravi Misra
Truist Securities
Neutral
$2.00+137.1% to target
Coverage
—
+ Follow
#4
PW
Patrick Wood
Morgan Stanley
Neutral
$6.00+611.3% to target
Coverage
—
+ Follow
ORGO stock forecast FAQ
What is ORGO's average 12-month price target?+
The 2 active firms with a live target average $5.00 for Organogenesis Holdings Inc over the next 12 months, ranging from a $8.00 high to a $2.00 low, as of Nov 19, 2026.
Is ORGO stock a Buy, Sell or Neutral right now?+
The current consensus is Insufficient coverage. Of the 2 active firms as of Nov 19, 2026, 1 rate it Buy or Strong Buy, 1 rate it Neutral, and 0 rate it Sell or Strong Sell.
What are the highest and lowest price targets for ORGO?+
The Street-high target is $8.00 (BTIG), and the Street-low is $2.00 (Truist Securities). The average of all 2 active-firm targets is $5.00.
How many active Wall Street firms cover ORGO?+
2 active firms have a recognized rating on Organogenesis Holdings Inc as of Nov 19, 2026, and 2 active firms carry a live 12-month price target.
Who is the most accurate analyst covering ORGO?+
Among analysts who currently cover ORGO, Ryan Zimmerman of BTIG has the strongest overall Quantellect track record (Rank #212). Their current call is Buy with a $8.00 target.
What is Organogenesis Holdings Inc's projected EPS for next quarter?+
The consensus estimate is $-0.16 per share (range $-0.18 – $-0.14) across 2 analysts. Full-year EPS is projected at $-1.43, rising to $-0.54 the following year.
How much revenue is Organogenesis Holdings Inc expected to report next quarter?+
Consensus revenue is $52.4M (range $48.9M – $55.8M). Full-year revenue is projected at $187.8M, growing to $234.7M next year.
Have analysts been upgrading or downgrading ORGO lately?+
As of Nov 19, 2026, 1 of 2 active firms rate ORGO a Buy (1 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their ORGO calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.